I-DireCT

Immune DIREcted and Cancer-selective immunoTherapy


Description

I-DireCT is a European Industrial Doctorate (EID) training network designed to provide training and carry out breakthrough research on the rapidly expanding and high impact field of cancer immunotherapy in a carefully integrated academic and inter-sectoral programme. Hereby, the consortium aims to develop next-generation immunotherapeutics and deliver a set of early stage researchers uniquely qualified for a career in academia and/or industry.

Coordinator
Prof. Edwin Bremer
Academisch Ziekenhuis Groningen
Email
Programme
Horizon 2020 & sub-programmes
Duration
57 months (January 2019 - September 2023)
Project funding
€ 2,533,358.34
Project partners
5
Project website
https://i-direct-itn.eu/